HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CP-654577

reduces the levels of the activated form of mitogen-activated protein kinase, increases the levels of cyclin-dependent kinase inhibitor p27(kip1) and reduces expression of cyclins D and E; structure in first source
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Pustilnik, Leslie R: 1 article (08/2003)
2. Iwata, Kenneth K: 1 article (08/2003)
3. Boscoe, Brian P: 1 article (08/2003)
4. Miller, Penny E: 1 article (08/2003)
5. Jani, Jitesh P: 1 article (08/2003)
6. Rossi, Ann Marie K: 1 article (08/2003)
7. Liu, Zhengyu: 1 article (08/2003)
8. Emerson, Erling: 1 article (08/2003)
9. Provoncha, Kathleen: 1 article (08/2003)
10. Cox, Eric D: 1 article (08/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Cyclin-Dependent Kinase Inhibitor p27
2. Cyclins
3. Protein Kinases (Protein Kinase)
4. Phosphotransferases (Kinase)